These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6135394)

  • 21. Pharmacogenetics of antihypertensive treatment.
    Arnett DK; Claas SA; Glasser SP
    Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The central hemodynamics and renin-angiotensin-aldosterone system in servicemen with arterial hypertension who participated in battle actions].
    Rakov AL; Mareev VIu; Bagmet AD; Shlyk SV
    Voen Med Zh; 2000 May; 321(5):21-4. PubMed ID: 10860446
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 24. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M
    Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The renin-angiotensin-aldosterone system: focus on its distinct role in arterial hypertension and its various inhibitors as a therapeutic strategy to effectively lower blood pressure.
    Soldner A; Spahn-Langguth H; Mutschler E
    Pharmazie; 1996 Nov; 51(11):783-99. PubMed ID: 8985974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the renin-angiotensin-aldosterone system and cough.
    Lacourcière Y; Lefebvre J
    Can J Cardiol; 1995 Aug; 11 Suppl F():33F-39F. PubMed ID: 7664216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 33. [Renin-angiotensin system and arterial hypertension. Mechanism of action of beta-blockers and captopril].
    Staroukine M; Giot JM; Jacobs W; Verniory A
    Bull Mem Acad R Med Belg; 1982; 137(12):723-36. PubMed ID: 6136306
    [No Abstract]   [Full Text] [Related]  

  • 34. Dual blockade of renin-angiotensin system. Data do not support claimed benefit of combination over single treatment.
    McCormack J; Levine M
    BMJ; 2001 May; 322(7295):1183. PubMed ID: 11379586
    [No Abstract]   [Full Text] [Related]  

  • 35. [Dual blockade of the renin-angiotensin system--is it of clinical significance?].
    Pedersen OL
    Ugeskr Laeger; 2004 Oct; 166(43):3797. PubMed ID: 15544107
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypertension, the renin-angiotensin system and perindopril. First International Symposium on Perindopril. Paris, France, October 29, 1989.
    Clin Exp Hypertens A; 1989; 11 Suppl 2():459-623. PubMed ID: 2605797
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hypertensive treatment in light of the latest discoveries in the renin-angiotensin system].
    Traub Y
    Harefuah; 1996 Feb; 130(3):195-9. PubMed ID: 8682399
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beta-adrenergic blockers and renin-angiotensin-aldosterone system in healthy individuals and patients with arterial hypertension].
    Miranda B; Ruilope L; Mancheño E; Arribas F; García-Robles R; Alcázar JM; Nieto J; Sancho J; Rodicio JL
    Med Clin (Barc); 1984 Nov; 83(14):572-4. PubMed ID: 6513646
    [No Abstract]   [Full Text] [Related]  

  • 39. [Etiological studies of hypertension. A Renin-angiotension-aldosterone system].
    Ideishi M; Arakawa K
    Nihon Rinsho; 1984 Feb; 42(2):271-6. PubMed ID: 6143838
    [No Abstract]   [Full Text] [Related]  

  • 40. Direct renin inhibition with aliskiren in hypertension and target organ damage.
    Müller DN; Luft FC
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):221-8. PubMed ID: 17699210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.